Search research articles
Contact Us
Filters
Showing results (281-290 of 437) with videos related to
Page
of 44
Sort By:
Clinical Immunology (Orlando, Fla.)
|
June 11, 2021
Abatacept for treatment-refractory pediatric CTLA4-haploinsufficiency
Anna-Lisa Lanz, Martin Riester, Philipp Peters, et al.
The Journal of Allergy and Clinical Immunology
|
December 17, 2013
Lesson from hypomorphic recombination-activating gene (RAG) mutations: Why asymptomatic siblings should also be tested
Catharina Schuetz, Ulrich Pannicke, Eva-Maria Jacobsen, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 17, 2003
Indole amide hydroxamic acids as potent inhibitors of histone deacetylases
Yujia Dai, Yan Guo, Jun Guo, et al.
Journal of Hazardous Materials
|
November 10, 2009
Concentrations of polybrominated diphenyl ethers in breast milk correlated to maternal age, education level, and occupational exposure
H Albert Chao, Solomon Chih-Cheng Chen, Ching-Mine Chang, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
|
October 29, 2020
Outcome of chronic granulomatous disease - Conventional treatment vs stem cell transplantation
Cinzia Dedieu, Michael H Albert, Nizar Mahlaoui, et al.
British Journal of Haematology
|
March 5, 2014
Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia
Peter Lang, Heiko-Manuel Teltschik, Tobias Feuchtinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2012
Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation
Vanya Icheva, Simone Kayser, Daniel Wolff, et al.
Pediatric Blood & Cancer
|
September 17, 2011
Sorafenib and cisplatin/doxorubicin (PLADO) in pediatric hepatocellular carcinoma
Irene Schmid, Beate Häberle, Michael H Albert, et al.
European Journal of Pharmacology
|
April 23, 1997
Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist
D H Albert, T J Magoc, P Tapang, et al.
Behavioural Brain Research
|
September 9, 2018
Nucleus incertus ablation disrupted conspecific recognition and modified immediate early gene expression patterns in 'social brain' circuits of rats
C García-Díaz, M J Sánchez-Catalán, E Castro-Salazar, et al.
Page
of 44
Search research articles
Search
Showing results (281-290 of 437) with videos related to
Sort By:
Page
of 44
Clinical Immunology (Orlando, Fla.)
|
June 11, 2021
Abatacept for treatment-refractory pediatric CTLA4-haploinsufficiency
Anna-Lisa Lanz, Martin Riester, Philipp Peters, et al.
The Journal of Allergy and Clinical Immunology
|
December 17, 2013
Lesson from hypomorphic recombination-activating gene (RAG) mutations: Why asymptomatic siblings should also be tested
Catharina Schuetz, Ulrich Pannicke, Eva-Maria Jacobsen, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 17, 2003
Indole amide hydroxamic acids as potent inhibitors of histone deacetylases
Yujia Dai, Yan Guo, Jun Guo, et al.
Journal of Hazardous Materials
|
November 10, 2009
Concentrations of polybrominated diphenyl ethers in breast milk correlated to maternal age, education level, and occupational exposure
H Albert Chao, Solomon Chih-Cheng Chen, Ching-Mine Chang, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
|
October 29, 2020
Outcome of chronic granulomatous disease - Conventional treatment vs stem cell transplantation
Cinzia Dedieu, Michael H Albert, Nizar Mahlaoui, et al.
British Journal of Haematology
|
March 5, 2014
Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia
Peter Lang, Heiko-Manuel Teltschik, Tobias Feuchtinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2012
Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation
Vanya Icheva, Simone Kayser, Daniel Wolff, et al.
Pediatric Blood & Cancer
|
September 17, 2011
Sorafenib and cisplatin/doxorubicin (PLADO) in pediatric hepatocellular carcinoma
Irene Schmid, Beate Häberle, Michael H Albert, et al.
European Journal of Pharmacology
|
April 23, 1997
Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist
D H Albert, T J Magoc, P Tapang, et al.
Behavioural Brain Research
|
September 9, 2018
Nucleus incertus ablation disrupted conspecific recognition and modified immediate early gene expression patterns in 'social brain' circuits of rats
C García-Díaz, M J Sánchez-Catalán, E Castro-Salazar, et al.
Page
of 44